|
|
Blood, 15 May 2008, Vol. 111, No. 10, pp. 4997-5007.
Prepublished online as a Blood First Edition Paper on March 12, 2008; DOI 10.1182/blood-2007-08-108597.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype
Richard C. A. Sainson1,
Douglas A. Johnston1,
Henry C. Chu1,
Matthew T. Holderfield1,
Martin N. Nakatsu1,
Steven P. Crampton1,
Jaeger Davis1,
Erin Conn1, and
Christopher C. W. Hughes1
1 Department of Molecular Biology and Biochemistry, University of California, Irvine
Pathological angiogenesis associated with wound healing often occurs subsequent to an inflammatory response that includes the secretion of cytokines such as tumor necrosis factor (TNF). Controversy exists on the angiogenic actions of TNF, with it being generally proangiogenic in vivo, but antiangiogenic in vitro. We find that whereas continuous administration of TNF in vitro or in vivo inhibits angiogenic sprouting, a 2- to 3-day pulse stimulates angiogenesis by inducing an endothelial "tip cell" phenotype. TNF induces the known tip cell genes platelet-derived growth factor B (PDGFB) and vascular endothelial cell growth factor receptor-2 (VEGFR2), while at the same time blocking signaling through VEGFR2, thus delaying the VEGF-driven angiogenic response. Notch signaling regulates tip cell function, and we find that TNF also induces the notch ligand jagged-1, through an NF B-dependent mechanism. Enrichment of jagged-1 in tip cells was confirmed by immunofluorescent staining as well as by laser capture microdissection/quantitative reverse-transcription–polymerase chain reaction (qRT-PCR) of tip cells sprouting in vitro. Thus, in angiogenesis, the temporal expression of TNF is critical: it delays angiogenesis initially by blocking signaling through VEGFR2, but in addition by inducing a tip cell phenotype through an NF B-dependent pathway, it concomitantly primes endothelial cells (ECs) for sprouting once the initial inflammatory wave has passed.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Gabrielli, E. V. Avvedimento, and T. Krieg
Scleroderma
N. Engl. J. Med.,
May 7, 2009;
360(19):
1989 - 2003.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Al-Mahmood, S. Colin, N. Farhat, E. Thorin, C. Steverlynck, and S. Chemtob
Potent in Vivo Antiangiogenic Effects of GS-101 (5'-TATCCGGAGGGCTCGCCATGCTGCT-3'), an Antisense Oligonucleotide Preventing the Expression of Insulin Receptor Substrate-1
J. Pharmacol. Exp. Ther.,
May 1, 2009;
329(2):
496 - 504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. De Smet, I. Segura, K. De Bock, P. J. Hohensinner, and P. Carmeliet
Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way
Arterioscler Thromb Vasc Biol,
May 1, 2009;
29(5):
639 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Blackburn and C. E. Brinckerhoff
Matrix Metalloproteinase-1 and Thrombin Differentially Activate Gene Expression in Endothelial Cells via PAR-1 and Promote Angiogenesis
Am. J. Pathol.,
December 1, 2008;
173(6):
1736 - 1746.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|